Search

Your search keyword '"Boomsma, Martijn F"' showing total 343 results
Start Over Author "Boomsma, Martijn F"
343 results on '"Boomsma, Martijn F"'

1. Deep learning on CT scans to predict checkpoint inhibitor treatment outcomes in advanced melanoma

Author

Ter Maat, Laurens S., De Mooij, Rob A. J., Van Duin, Isabella A. J., Verhoeff, Joost J. C., Elias, Sjoerd G., Leiner, Tim, van Amsterdam, Wouter A. C., Troenokarso, Max F., Arntz, Eran R. A. N., Van den Berkmortel, Franchette W. P. J., Boers-Sonderen, Marye J., Boomsma, Martijn F., Van den Eertwegh, Fons J. M., de Groot, Jan Willem, Hospers, Geke A. P., Piersma, Djura, Vreugdenhil, Art, Westgeest, Hans M., Kapiteijn, Ellen, De Wit, Ardine A., Blokx, Willeke A. M., Van Diest, Paul J., De Jong, Pim A., Pluim, Josien P. W., Suijkerbuijk, Karijn P. M., and Veta, Mitko

Published
2024
Full Text
View/download PDF

4. Adjuvant dendritic cell therapy in stage IIIB/C melanoma: the MIND-DC randomized phase III trial

Author

Bol, Kalijn F., Schreibelt, Gerty, Bloemendal, Martine, van Willigen, Wouter W., Hins-de Bree, Simone, de Goede, Anna L., de Boer, Annemiek J., Bos, Kevin J. H., Duiveman-de Boer, Tjitske, Olde Nordkamp, Michel A. M., van Oorschot, Tom G. M., Popelier, Carlijn J., Pots, Jeanne M., Scharenborg, Nicole M., van de Rakt, Mandy W. M. M., de Ruiter, Valeska, van Meeteren, Wilmy S., van Rossum, Michelle M., Croockewit, Sandra J., Koeneman, Bouke J., Creemers, Jeroen H. A., Wortel, Inge M. N., Angerer, Caroline, Brüning, Mareke, Petry, Katja, Dzionek, Andrzej, van der Veldt, Astrid A., van Grünhagen, Dirk J., Werner, Johanna E. M., Bonenkamp, Johannes J., Haanen, John B. A. G., Boers-Sonderen, Marye J., Koornstra, Rutger H. T., Boomsma, Martijn F., Aarntzen, Erik H. J., Gotthardt, Martin, Nagarajah, James, de Witte, Theo J. M., Figdor, Carl G., de Wilt, Johannes H. W., Textor, Johannes, de Groot, Jan Willem B., Gerritsen, Winald R., and de Vries, I. Jolanda M.

Published
2024
Full Text
View/download PDF

15. CT radiomics compared to a clinical model for predicting checkpoint inhibitor treatment outcomes in patients with advanced melanoma

Author

ter Maat, Laurens S., van Duin, Isabella A.J., Elias, Sjoerd G., Leiner, Tim, Verhoeff, Joost J.C., Arntz, Eran R.A.N., Troenokarso, Max F., Blokx, Willeke A.M., Isgum, Ivana, de Wit, Geraldine A., van den Berkmortel, Franchette W.P.J., Boers-Sonderen, Marye J., Boomsma, Martijn F., van den Eertwegh, Fons J.M., de Groot, Jan Willem B., Piersma, Djura, Vreugdenhil, Art, Westgeest, Hans M., Kapiteijn, Ellen, van Diest, Paul J., Pluim, Josien P.W., de Jong, Pim A., Suijkerbuijk, Karijn P.M., and Veta, Mitko

Published
2023
Full Text
View/download PDF

20. Focused Ultrasound and RadioTHERapy for non-invasive palliative pain treatment in patients with bone metastasis: a study protocol for the three armed randomized controlled FURTHER trial

Author

Slotman, Derk J., Bartels, Marcia M. T. J., Ferrer, Cyril J., Bos, Clemens, Bartels, Lambertus W., Boomsma, Martijn F., Phernambucq, Erik C. J., Nijholt, Ingrid M., Morganti, Alessio G., Siepe, Giambattista, Buwenge, Milly, Grüll, Holger, Bratke, Grischa, Yeo, Sin Yuin, Blanco Sequeiros, Roberto, Minn, Heikki, Huhtala, Mira, Napoli, Alessandro, De Felice, Francesca, Catalano, Carlo, Bazzocchi, Alberto, Gasperini, Chiara, Campanacci, Laura, Simões Corrêa Galendi, Julia, Müller, Dirk, Braat, Manon N. G. J. A., Moonen, Chrit, and Verkooijen, Helena M.

Published
2022
Full Text
View/download PDF

23. Combining radiotherapy and focused ultrasound for pain palliation of cancer induced bone pain; a stage I/IIa study according to the IDEAL framework

Author

Bartels, Marcia M.T.J., Verpalen, Inez M., Ferrer, Cyril J., Slotman, Derk J., Phernambucq, Erik C.J., Verhoeff, Joost J.C., Eppinga, Wietse S.C., Braat, Manon N.G.J.A., van den Hoed, Rolf D., van 't Veer-Ten Kate, Miranda, de Boer, Erwin, Naber, Harry R., Nijholt, Ingrid M., Bartels, Lambertus W., Bos, Clemens, Moonen, Chrit T.W., Boomsma, Martijn F., and Verkooijen, Helena M.

Published
2021
Full Text
View/download PDF

24. Proceedings of the 15th International Newborn Brain Conference: Neuro-imaging studies.

Author

Al-Garni, AbdulAziz, Aslam, Saima, Assis, Zarina, Avanaki, Karman, Bagnato, Maria Chiara, Bainbridge, Alan, Baruteau, Kelly Pegoretti, Beghini, Renzo, Benavides, Juliana, Benlamri, Amina, Berger, Angelika, Bhroin, Megan Ni, Bissolo, Francesca, Bokde, Arun, Bonafiglia, Elena, Boomsma, Martijn, Boomsma, Martijn F., Boswinkel, Vivanne, Boylan, Geraldine, and Buchmayer, Julia

Subjects
DIFFUSION magnetic resonance imaging, FUNCTIONAL magnetic resonance imaging, MEDICAL sciences, MORPHOLOGY, LOW birth weight, CEREBRAL anoxia-ischemia, CRYING
Abstract

This document is a collection of abstracts from the Journal of Neonatal - Perinatal Medicine. The abstracts cover various topics related to neonatal neurodevelopment and brain abnormalities in preterm infants. One study focuses on the use of MRI in predicting long-term outcomes in infants with Hypoxic Ischemic Encephalopathy. Another study explores the prediction of post-hemorrhagic ventricular dilatation in preterm infants with intraventricular hemorrhage. A third study examines the impact of cerebellar hemorrhage on the neurodevelopmental outcomes of extremely preterm infants. The fourth abstract compares the utility of early and late MRI in evaluating infants with Neonatal Encephalopathy. Additionally, there is a study investigating the impact of SARS-CoV-2 infection during pregnancy on neonatal neurological outcomes. Lastly, a study explores the hemodynamic responses associated with spontaneous neural activity in the early developing brain. These abstracts provide valuable insights into neonatal neurodevelopment and brain abnormalities in preterm infants. [Extracted from the article]

Published
2024
Full Text
View/download PDF

26. Feasibility study to unveil the potential: considerations of constrained spherical deconvolution tractography with unsedated neonatal diffusion brain MRI data

Author

Beeldverwerking ISI, Cancer, Brain, Verschuur, Anouk S., Tax, Chantal M.W., Boomsma, Martijn F., Carlson, Helen L., van Wezel-Meijler, Gerda, King, Regan, Leemans, Alexander, Leijser, Lara M., Beeldverwerking ISI, Cancer, Brain, Verschuur, Anouk S., Tax, Chantal M.W., Boomsma, Martijn F., Carlson, Helen L., van Wezel-Meijler, Gerda, King, Regan, Leemans, Alexander, and Leijser, Lara M.

Published
2024

27. Development and validation of a deep learning-based method for automatic measurement of uterus, fibroid, and ablated volume in MRI after MR-HIFU treatment of uterine fibroids

Author

Trialbureau Beeld, Cancer, Divisie Beeld & Oncologie, Beeldverwerking ISI, Researchgr. Beeldg. Moleculaire Interv., Regenerative Medicine and Stem Cells, Brain, Slotman, Derk J., Bartels, Lambertus W., Nijholt, Ingrid M., Huirne, Judith A.F., Moonen, Chrit T.W., Boomsma, Martijn F., Trialbureau Beeld, Cancer, Divisie Beeld & Oncologie, Beeldverwerking ISI, Researchgr. Beeldg. Moleculaire Interv., Regenerative Medicine and Stem Cells, Brain, Slotman, Derk J., Bartels, Lambertus W., Nijholt, Ingrid M., Huirne, Judith A.F., Moonen, Chrit T.W., and Boomsma, Martijn F.

Published
2024

28. Waste analysis and energy use estimation during MR-HIFU treatment: first steps towards calculating total environmental impact

Author

MS VPG/Gynaecologie, Strategische Impuls RvB ISI, Trialbureau Beeld, Beeldverwerking ISI, Brain, Anneveldt, Kimberley J., Nijholt, Ingrid M., Schutte, Joke M., Hehenkamp, Wouter J.K., Veersema, Sebastiaan, Huirne, Judith A.F., Boomsma, Martijn F., MS VPG/Gynaecologie, Strategische Impuls RvB ISI, Trialbureau Beeld, Beeldverwerking ISI, Brain, Anneveldt, Kimberley J., Nijholt, Ingrid M., Schutte, Joke M., Hehenkamp, Wouter J.K., Veersema, Sebastiaan, Huirne, Judith A.F., and Boomsma, Martijn F.

Published
2024

29. Effectiveness and complication rates of high intensity focused ultrasound treatment for abdominal wall endometriosis: A systematic review

Author

MS Radiologie, Cancer, Divisie Beeld & Oncologie, Beeldverwerking ISI, Brain, Knorren, Elisabeth R., de Ridder, Larissa A., Nijholt, Ingrid M., Dijkstra, Jeroen R., Braat, Manon N.G.J.A., Huirne, Judith A.F., Boomsma, Martijn F., Schutte, Joke M., MS Radiologie, Cancer, Divisie Beeld & Oncologie, Beeldverwerking ISI, Brain, Knorren, Elisabeth R., de Ridder, Larissa A., Nijholt, Ingrid M., Dijkstra, Jeroen R., Braat, Manon N.G.J.A., Huirne, Judith A.F., Boomsma, Martijn F., and Schutte, Joke M.

Published
2024

30. Intravoxel incoherent motion (IVIM)-derived perfusion fraction mapping for the visual evaluation of MR-guided high intensity focused ultrasound (MR-HIFU) ablation of uterine fibroids

Author

Trialbureau Beeld, Cancer, Beeldverwerking ISI, Precision Imaging Group, Brain, Circulatory Health, Highfield Research Group, Researchgr. Beeldg. Moleculaire Interv., Regenerative Medicine and Stem Cells, Slotman, Derk J, Bartels, Lambertus W, Nijholt, Ingrid M, Froeling, Martijn, Huirne, Judith A F, Moonen, Chrit T W, Boomsma, Martijn F, Trialbureau Beeld, Cancer, Beeldverwerking ISI, Precision Imaging Group, Brain, Circulatory Health, Highfield Research Group, Researchgr. Beeldg. Moleculaire Interv., Regenerative Medicine and Stem Cells, Slotman, Derk J, Bartels, Lambertus W, Nijholt, Ingrid M, Froeling, Martijn, Huirne, Judith A F, Moonen, Chrit T W, and Boomsma, Martijn F

Published
2024

31. An artificial intelligence algorithm for pulmonary embolism detection on polychromatic computed tomography: performance on virtual monochromatic images

Author

MS Radiologie, Cancer, Circulatory Health, Researchgr. Systems Radiology, Infection & Immunity, Regenerative Medicine and Stem Cells, Beeldverwerking ISI, Brain, Langius-Wiffen, Eline, Nijholt, Ingrid M., van Dijk, Rogier A., de Boer, Erwin, Nijboer-Oosterveld, Jacqueline, Veldhuis, Wouter B., de Jong, Pim A., Boomsma, Martijn F., MS Radiologie, Cancer, Circulatory Health, Researchgr. Systems Radiology, Infection & Immunity, Regenerative Medicine and Stem Cells, Beeldverwerking ISI, Brain, Langius-Wiffen, Eline, Nijholt, Ingrid M., van Dijk, Rogier A., de Boer, Erwin, Nijboer-Oosterveld, Jacqueline, Veldhuis, Wouter B., de Jong, Pim A., and Boomsma, Martijn F.

Published
2024

32. Added value of an artificial intelligence algorithm in reducing the number of missed incidental acute pulmonary embolism in routine portal venous phase chest CT

Author

Researchgr. Systems Radiology, Cancer, Circulatory Health, Infection & Immunity, Regenerative Medicine and Stem Cells, MS Radiologie, Onderzoek Beeld, Langius-Wiffen, Eline, de Jong, Pim A, Mohamed Hoesein, Firdaus A, Dekker, Lisette, van den Hoven, Andor F, Nijholt, Ingrid M, Boomsma, Martijn F, Veldhuis, Wouter B, Researchgr. Systems Radiology, Cancer, Circulatory Health, Infection & Immunity, Regenerative Medicine and Stem Cells, MS Radiologie, Onderzoek Beeld, Langius-Wiffen, Eline, de Jong, Pim A, Mohamed Hoesein, Firdaus A, Dekker, Lisette, van den Hoven, Andor F, Nijholt, Ingrid M, Boomsma, Martijn F, and Veldhuis, Wouter B

Published
2024

33. External validation of the RSNA 2020 pulmonary embolism detection challenge winning deep learning algorithm

Author

Trialbureau Beeld, Cancer, MS Radiologie, Circulatory Health, Researchgr. Systems Radiology, Infection & Immunity, Regenerative Medicine and Stem Cells, Beeldverwerking ISI, Brain, Langius-Wiffen, Eline, Slotman, Derk J., Groeneveld, Jorik, AC van Osch, Jochen, Nijholt, Ingrid M., de Boer, Erwin, Nijboer-Oosterveld, Jacqueline, Veldhuis, Wouter B., de Jong, Pim A., Boomsma, Martijn F., Trialbureau Beeld, Cancer, MS Radiologie, Circulatory Health, Researchgr. Systems Radiology, Infection & Immunity, Regenerative Medicine and Stem Cells, Beeldverwerking ISI, Brain, Langius-Wiffen, Eline, Slotman, Derk J., Groeneveld, Jorik, AC van Osch, Jochen, Nijholt, Ingrid M., de Boer, Erwin, Nijboer-Oosterveld, Jacqueline, Veldhuis, Wouter B., de Jong, Pim A., and Boomsma, Martijn F.

Published
2024

34. Adjuvant dendritic cell therapy in stage IIIB/C melanoma:the MIND-DC randomized phase III trial

Author

Bol, Kalijn F., Schreibelt, Gerty, Bloemendal, Martine, van Willigen, Wouter W., Hins-de Bree, Simone, de Goede, Anna L., de Boer, Annemiek J., Bos, Kevin J.H., Duiveman-de Boer, Tjitske, Olde Nordkamp, Michel A.M., van Oorschot, Tom G.M., Popelier, Carlijn J., Pots, Jeanne M., Scharenborg, Nicole M., van de Rakt, Mandy W.M.M., de Ruiter, Valeska, van Meeteren, Wilmy S., van Rossum, Michelle M., Croockewit, Sandra J., Koeneman, Bouke J., Creemers, Jeroen H.A., Wortel, Inge M.N., Angerer, Caroline, Brüning, Mareke, Petry, Katja, Dzionek, Andrzej, van der Veldt, Astrid A., van Grünhagen, Dirk J., Werner, Johanna E.M., Bonenkamp, Johannes J., Haanen, John B.A.G., Boers-Sonderen, Marye J., Koornstra, Rutger H.T., Boomsma, Martijn F., Aarntzen, Erik H.J., Gotthardt, Martin, Nagarajah, James, de Witte, Theo J.M., Figdor, Carl G., de Wilt, Johannes H.W., Textor, Johannes, de Groot, Jan Willem B., Gerritsen, Winald R., de Vries, I. Jolanda M., Bol, Kalijn F., Schreibelt, Gerty, Bloemendal, Martine, van Willigen, Wouter W., Hins-de Bree, Simone, de Goede, Anna L., de Boer, Annemiek J., Bos, Kevin J.H., Duiveman-de Boer, Tjitske, Olde Nordkamp, Michel A.M., van Oorschot, Tom G.M., Popelier, Carlijn J., Pots, Jeanne M., Scharenborg, Nicole M., van de Rakt, Mandy W.M.M., de Ruiter, Valeska, van Meeteren, Wilmy S., van Rossum, Michelle M., Croockewit, Sandra J., Koeneman, Bouke J., Creemers, Jeroen H.A., Wortel, Inge M.N., Angerer, Caroline, Brüning, Mareke, Petry, Katja, Dzionek, Andrzej, van der Veldt, Astrid A., van Grünhagen, Dirk J., Werner, Johanna E.M., Bonenkamp, Johannes J., Haanen, John B.A.G., Boers-Sonderen, Marye J., Koornstra, Rutger H.T., Boomsma, Martijn F., Aarntzen, Erik H.J., Gotthardt, Martin, Nagarajah, James, de Witte, Theo J.M., Figdor, Carl G., de Wilt, Johannes H.W., Textor, Johannes, de Groot, Jan Willem B., Gerritsen, Winald R., and de Vries, I. Jolanda M.

Abstract

Autologous natural dendritic cells (nDCs) treatment can induce tumor-specific immune responses and clinical responses in cancer patients. In this phase III clinical trial (NCT02993315), 148 patients with resected stage IIIB/C melanoma were randomized to adjuvant treatment with nDCs (n = 99) or placebo (n = 49). Active treatment consisted of intranodally injected autologous CD1c+ conventional and plasmacytoid DCs loaded with tumor antigens. The primary endpoint was the 2-year recurrence-free survival (RFS) rate, whereas the secondary endpoints included median RFS, 2-year and median overall survival, adverse event profile, and immunological response The 2-year RFS rate was 36.8% in the nDC treatment group and 46.9% in the control group (p = 0.31). Median RFS was 12.7 months vs 19.9 months, respectively (hazard ratio 1.25; 90% CI: 0.88−1.79; p = 0.29). Median overall survival was not reached in both treatment groups (hazard ratio 1.32; 90% CI: 0.73−2.38; p = 0.44). Grade 3−4 study-related adverse events occurred in 5% and 6% of patients. Functional antigen-specific T cell responses could be detected in 67.1% of patients tested in the nDC treatment group vs 3.8% of patients tested in the control group (p < 0.001). In conclusion, while adjuvant nDC treatment in stage IIIB/C melanoma patients generated specific immune responses and was well tolerated, no benefit in RFS was observed.

Published
2024

39. No Difference in Revision Rates and High Survival Rates in Large-head Metal-on-metal THA Versus Metal-on-polyethylene THA: Long-term Results of a Randomized Controlled Trial.

Author

Spierenburg, Willemijn, de Vries, Astrid J., Boomsma, Martijn F., Siepelinga, S., Wetzels, Tom, and van Raaij, Jos J. A. M.

Subjects
OVERALL survival, NURSE practitioners, SURGICAL complications, RANDOMIZED controlled trials, REOPERATION
Abstract

Background Pseudotumor formation is a well-known complication in metal-on-metal (MoM) THA. Pseudotumors combined with elevated serum ion levels and complaints from patients can lead to high revision rates. Long-term (> 10 years) results obtained from randomized trials comparing large-head MoM THA and conventional metal-on-polyethylene (MoP) THA are lacking regarding revision and survival rates, pseudotumor formation, functional outcomes, and serum ion levels. Questions/purposes At 10 years of follow-up, (1)what is the difference in survival and revision rates between large-head (38 to 60 mm) MoM THA and conventional 28-mm MoP THA? (2) What is the difference in pseudotumor formation between large-headMoM THA and MoP THA? (3) Is there a difference in functional outcome between large-head MoM THA and MoP THA? (4)What is the difference in serum ion levels between large-head MoM THA and MoP THA? Methods Between January 2006 and December 2008, 104 patients were randomized to receive either cementless MoM THA (50 patients) or cementless MoP THA (54 patients). In all, 78% (81 of 104) of patients completed the 10-year postoperative follow-up: 36 patients with MoM THA (72%; six patients lost to follow-up) and 45 with MoP THA (83%; four lost to follow-up). In the MoM group, 47% (17) were men, and the patients had a mean 6 SD age of 6065 years. In the MoP group, 38% (17) were men, and the patients had a mean age of 61 6 5 years. All baseline characteristics were similar between the groups. At 10 years of follow-up, all patient records were screened for revision surgery or complications, and the primary endpoint was survivorship free from revision for any cause at the 10-year follow-up interval, which we analyzed using a Kaplan-Meier survival analysis. All patients had a CT scan to determine the pseudotumor classification, which was reviewed by an independent radiologist. Functional outcome was measured using the patient-reported Oxford Hip Score and Harris Hip Score; the latter was assessed by a blinded nurse practitioner. Finally, serum ion cobalt and chrome concentrations were measured at 10 years postoperatively. Because the a priori sample size calculation for this randomized controlled trial was based on a different endpoint, a post hoc power analysis was performed for this long-term follow-up study, with survival as the primary outcome. It showed that considering the number of included patients, this study would have sufficient power (one-sided testing, alpha 0.05, power 80%) to discern a difference of 20% in the survival rate between the MoP and MoM groups (95% versus 75%). Results With the numbers available, there was no difference in survivorship free from revision for any cause between the MoP group andMoM group at 10 years (95% [95% CI 85% to 98%] versus 92% [95% CI 82% to 98%]; p = 0.6). A higher percentage of patients in theMoMgroup had pseudotumors on CT than those in the MoP group did, but pseudotumors were observed in both groups (56% [20 of 36] in the MoM group versus 22% [10 of 45] in theMoP group, relative risk 1.8 [95% CI 1.2 to 2.6]; p = 0.002). A higher proportion of elevated cobalt and chrome levels was found in the MoM group (19% and 14%, respectively) than in the MoP group (0% for both cobalt and chrome) (cobalt: RR 1.2 [95% CI 1.1 to 1.5]; p = 0.002; chrome: RR 1.2 [95% CI 1.0 to 1.3]; p = 0.01). In 25% of the patientswith pseudotumors (5 of 20 patients), there were elevated serum cobalt levels. None of the 23 patients without pseudotumors had elevated cobalt levels (RR 1.3 [95% CI 1.0 to 1.7]; p = 0.01). There was no difference in functional outcome between study groups, nor a difference between patients with a pseudotumor and those without. Conclusion This study showed that the survival of patients with large-head MoM THA was high and comparable to that of those with MoP THA, which contrasts with the high revision rates reported by others. Although some patients with MoP THAs experienced pseudotumors, the risk of a pseudotumor was much greater in MoM hips, and serum ion levels were higher in patients who received an MoM THA. For these reasons and unknown future complications, continued surveillance of patients with MoM THAs seems important. Level of Evidence Level I, therapeutic study. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

43. 601: Eligibility for MR-HIFU in patients with non-spinal bone metastases referred for radiotherapy

Author

Hovenier, Renée, Slotman, Derk J., Gasperini, Chiara, Zamagni, Alice, Huhtala, Mira, Bartels, Lambertus W., Braat, Manon N.G.J.A., Eppinga, Wietse S.C., Kasperts, Nicolien, Phernambucq, Erik C.J., Boomsma, Martijn F., Nijholt, Ingrid M., Sequieros, Roberto Blanco, Bazzocchi, Alberto, Morganti, Alessio G., Moonen, Chrit T.W., Bos, Clemens, and Verkooijen, Helena M.

Published
2024
Full Text
View/download PDF

48. Retrospective batch analysis to evaluate the diagnostic accuracy of a clinically deployed AI algorithm for the detection of acute pulmonary embolism on CTPA

Author

Researchgr. Systems Radiology, Cancer, Circulatory Health, Infection & Immunity, Regenerative Medicine and Stem Cells, MS Radiologie, Arts-assistenten Radiologie, Langius-Wiffen, Eline, de Jong, Pim A., Hoesein, Firdaus A.Mohamed, Dekker, Lisette, van den Hoven, Andor F., Nijholt, Ingrid M., Boomsma, Martijn F., Veldhuis, Wouter B., Researchgr. Systems Radiology, Cancer, Circulatory Health, Infection & Immunity, Regenerative Medicine and Stem Cells, MS Radiologie, Arts-assistenten Radiologie, Langius-Wiffen, Eline, de Jong, Pim A., Hoesein, Firdaus A.Mohamed, Dekker, Lisette, van den Hoven, Andor F., Nijholt, Ingrid M., Boomsma, Martijn F., and Veldhuis, Wouter B.

Published
2023

49. CT radiomics compared to a clinical model for predicting checkpoint inhibitor treatment outcomes in patients with advanced melanoma

Author

Cancer, Beeldverwerking ISI, MS Medische Oncologie, Epi Kanker Team C, JC onderzoeksprogramma Kanker, MS Radiotherapie, Circulatory Health, Pathologie Pathologen staf, HEE, JC onderzoeksprogramma Methodologie, Pathologie, Medische Beeldanalyse, Researchgr. Systems Radiology, Infection & Immunity, Regenerative Medicine and Stem Cells, Ter Maat, Laurens S, van Duin, Isabella A J, Elias, Sjoerd G, Leiner, Tim, Verhoeff, Joost J C, Arntz, Eran R A N, Troenokarso, Max F, Blokx, Willeke A M, Isgum, Ivana, de Wit, Geraldine A, van den Berkmortel, Franchette W P J, Boers-Sonderen, Marye J, Boomsma, Martijn F, van den Eertwegh, Fons J M, de Groot, Jan Willem B, Piersma, Djura, Vreugdenhil, Art, Westgeest, Hans M, Kapiteijn, Ellen, van Diest, Paul J, Pluim, Josien P W, de Jong, Pim A, Suijkerbuijk, Karijn P M, Veta, Mitko, Cancer, Beeldverwerking ISI, MS Medische Oncologie, Epi Kanker Team C, JC onderzoeksprogramma Kanker, MS Radiotherapie, Circulatory Health, Pathologie Pathologen staf, HEE, JC onderzoeksprogramma Methodologie, Pathologie, Medische Beeldanalyse, Researchgr. Systems Radiology, Infection & Immunity, Regenerative Medicine and Stem Cells, Ter Maat, Laurens S, van Duin, Isabella A J, Elias, Sjoerd G, Leiner, Tim, Verhoeff, Joost J C, Arntz, Eran R A N, Troenokarso, Max F, Blokx, Willeke A M, Isgum, Ivana, de Wit, Geraldine A, van den Berkmortel, Franchette W P J, Boers-Sonderen, Marye J, Boomsma, Martijn F, van den Eertwegh, Fons J M, de Groot, Jan Willem B, Piersma, Djura, Vreugdenhil, Art, Westgeest, Hans M, Kapiteijn, Ellen, van Diest, Paul J, Pluim, Josien P W, de Jong, Pim A, Suijkerbuijk, Karijn P M, and Veta, Mitko

Published
2023

50. Factors Influencing the Adoption of Magnetic Resonance-Guided High-Intensity Focused Ultrasound for Painful Bone Metastases in Europe, A Group Concept Mapping Study

Author

Trialbureau Beeld, Researchgr. Beeldg. Moleculaire Interv., Cancer, Simões Corrêa Galendi, Julia, Siefen, Ann Cathrine, Moretti, Debora M., Yeo, Sin Yuin, Grüll, Holger, Bratke, Grischa, Morganti, Alessio Giuseppe, Bazzocchi, Alberto, Gasperini, Chiara, De Felice, Francesca, Blanco Sequeiros, Roberto, Huhtala, Mira, Nijholt, Ingrid M., Boomsma, Martijn F., Bos, Clemens, Verkooijen, Helena M., Müller, Dirk, Stock, Stephanie, Trialbureau Beeld, Researchgr. Beeldg. Moleculaire Interv., Cancer, Simões Corrêa Galendi, Julia, Siefen, Ann Cathrine, Moretti, Debora M., Yeo, Sin Yuin, Grüll, Holger, Bratke, Grischa, Morganti, Alessio Giuseppe, Bazzocchi, Alberto, Gasperini, Chiara, De Felice, Francesca, Blanco Sequeiros, Roberto, Huhtala, Mira, Nijholt, Ingrid M., Boomsma, Martijn F., Bos, Clemens, Verkooijen, Helena M., Müller, Dirk, and Stock, Stephanie

Published
2023

Catalog

Books, media, physical & digital resources
See catalog results